相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Mammalian dihydropyrimidine dehydrogenase
Dariush C. Forouzesh et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Clinical development of retroviral replicating vector Toca 511 for gene therapy of cancer
Sara A. Collins et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2021)
Capecitabine and Temozolomide in Advanced Lung Neuroendocrine Neoplasms
Taymeyah Al-Toubah et al.
ONCOLOGIST (2020)
Immune modulation after Toca 511 and Toca FC treatment of colorectal cancer patients.
Gerald Steven Falchook et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Effect of Vocimagene Amiretrorepvec in Combination With Flucytosine vs Standard of Care on Survival Following Tumor Resection in Patients With Recurrent High-Grade Glioma A Randomized Clinical Trial
Timothy F. Cloughesy et al.
JAMA ONCOLOGY (2020)
First-Line Nivolumab Plus Ipilimumab in Advanced Non-Small-Cell Lung Cancer (CheckMate 568): Outcomes by Programmed Death Ligand 1 and Tumor Mutational Burden as Biomarkers
Neal Ready et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
The Japanese Lung Cancer Society Guideline for non-small cell lung cancer, stage IV
Hiroaki Akamatsu et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2019)
Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial
Tony S. K. Mok et al.
LANCET (2019)
Therapeutic activity of retroviral replicating vector-mediated prodrug activator gene therapy for pancreatic cancer
Kazuho Inoko et al.
CANCER GENE THERAPY (2018)
Molecular Analyses Support the Safety and Activity of Retroviral Replicating Vector Toca 511 in Patients
Daniel J. Hogan et al.
CLINICAL CANCER RESEARCH (2018)
NCCN Guidelines® Insights Non- Small Cell Lung Cancer, Version 5.2018 Featured Updates to the NCCN Guidelines
David S. Ettinger et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2018)
Durable complete responses in some recurrent highgrade glioma patients treated with Toca 511+Toca FC
Timothy F. Cloughesy et al.
NEURO-ONCOLOGY (2018)
Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
Michael A. Postow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
DDX41 Recognizes RNA/DNA Retroviral Reverse Transcripts and Is Critical for In Vivo Control of Murine Leukemia Virus Infection
Spyridon Stavrou et al.
MBIO (2018)
A Retroviral Replicating Vector Encoding Cytosine Deaminase and 5-FC Induces Immune Memory in Metastatic Colorectal Cancer Models
Kader Yagiz et al.
MOLECULAR THERAPY-ONCOLYTICS (2018)
Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC
S. J. Antonia et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
VATS segmentectomy: past, present, and future
Seshiru Nakazawa et al.
GENERAL THORACIC AND CARDIOVASCULAR SURGERY (2018)
Retroviral replicating vector-mediated gene therapy achieves long-term control of tumor recurrence and leads to durable anticancer immunity
Kei Hiraoka et al.
NEURO-ONCOLOGY (2017)
Toca 511 gene transfer and treatment with the prodrug, 5-fluorocytosine, promotes durable antitumor immunity in a mouse glioma model
Leah A. Mitchell et al.
NEURO-ONCOLOGY (2017)
Natural killer T cells contribute to the control of acute retroviral infection
Elisabeth Littwitz-Salomon et al.
RETROVIROLOGY (2017)
The Eighth Edition Lung Cancer Stage Classification
Frank C. Detterbeck et al.
CHEST (2017)
The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer
Peter Goldstraw et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
Is VATS lobectomy standard of care for operable non-small cell lung cancer?
Fernando Vannucci et al.
LUNG CANCER (2016)
Phase 1 trial of vocimagene amiretrorepvec and 5-fluorocytosine for recurrent high-grade glioma
Timothy F. Cloughesy et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Palliative Care in Lung Cancer: A Review
Brett C. Bade et al.
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2016)
Antagonists of PD-1 and PD-L1 in Cancer Treatment
Evan J. Lipson et al.
SEMINARS IN ONCOLOGY (2015)
Efficacy of S-1 in non-small cell lung cancer
Masaaki Kawahara
EXPERT OPINION ON PHARMACOTHERAPY (2014)
Tetherin Promotes the Innate and Adaptive Cell-Mediated Immune Response against Retrovirus Infection In Vivo
Sam X. Li et al.
JOURNAL OF IMMUNOLOGY (2014)
Design and Selection of Toca 511 for Clinical Use: Modified Retroviral Replicating Vector With Improved Stability and Gene Expression
Omar D. Perez et al.
MOLECULAR THERAPY (2012)
Brain tumor eradication and prolonged survival from intratumoral conversion of 5-fluorocytosine to 5-fluorouracil using a nonlytic retroviral replicating vector
Derek Ostertag et al.
NEURO-ONCOLOGY (2012)
Sequential vs Concurrent Chemoradiation for Stage III Non-Small Cell Lung Cancer: Randomized Phase III Trial RTOG 9410
Walter J. Curran et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data
A. Auperin et al.
LANCET (2010)
Is capecitabine a new choice of treatment for lung adenocarcinoma? A case report involving partial response in second line of treatment and hypothesis of the biological basis
Cesar Mendiola et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2009)
Dramatic response with capecitabine after cranial radiation to the brain parenchymal and leptomeningeal metastases from lung cancer
Semra Paydas et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2009)
Effect of Postoperative Adjuvant Chemotherapy with Tegafur-Uracil on Survival in Patients with Stage IA Non-small Cell Lung Cancer An Exploratory Analysis from a Meta-Analysis of Six Randomized Controlled Trials
Chikuma Hamada et al.
JOURNAL OF THORACIC ONCOLOGY (2009)
Expression of Murine APOBEC3 Alleles in Different Mouse Strains and Their Effect on Mouse Mammary Tumor Virus Infection
Chioma M. Okeoma et al.
JOURNAL OF VIROLOGY (2009)
Host factors involved in resistance to retroviral infection
Hiroaki Takeuchi et al.
MICROBIOLOGY AND IMMUNOLOGY (2008)
The IASLC lung cancer staging project: Proposals for revision of the M descriptors in the forthcoming (seventh) edition of the TNM classification of lung cancer
Pieter E. Postmus et al.
JOURNAL OF THORACIC ONCOLOGY (2007)
Highly efficient gene delivery for bladder cancers by intravesically administered replication-competent retroviral vectors
Eiji Kikuchi et al.
CLINICAL CANCER RESEARCH (2007)
Therapeutic efficacy of replication-competent retrovirus vector-mediated suicide gene therapy in a multifocal colorectal cancer metastasis model
Kei Hiraoka et al.
CANCER RESEARCH (2007)
Tumor-selective gene expression in a hepatic metastasis model after locoregional delivery of a replication-competent retrovirus vector
Kei Hiraoka et al.
CLINICAL CANCER RESEARCH (2006)
Multicenter phase I study of repeated intratumoral delivery of adenoviral p53 in patients with advanced non-small-cell lung cancer
T Fujiwara et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Phase II study of weekly irinotecan plus capecitabine for chemotherapy-naive patients with advanced nonsmall cell lung carcinoma
JY Han et al.
CANCER (2005)
Single-shot, multicycle suicide gene therapy by replication-competent retrovirus vectors achieves long-term survival benefit in experimental glioma
CK Tai et al.
MOLECULAR THERAPY (2005)
Chemotherapy versus supportive care in advanced non-small cell lung cancer: improved survival without detriment to quality of life
SG Spiro et al.
THORAX (2004)
5-Fluorouracil: Mechanisms of action and clinical strategies
DB Longley et al.
NATURE REVIEWS CANCER (2003)
Highly efficient and tumor-restricted gene transfer to malignant gliomas by replication-competent retroviral vectors
WJ Wang et al.
HUMAN GENE THERAPY (2003)
A uniquely stable replication-competent retrovirus vector achieves efficient gene delivery in vitro and in solid tumors
CR Logg et al.
HUMAN GENE THERAPY (2001)
分享论文
